Skip to content

China Resources Pharmaceutical

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    China Resources Pharmaceutical announces 10% stake purchase in Yongtai Bioscience

    China Resources Pharmaceutical said its wholly owned subsidiary purchased 51,458,400 ordinary shares in Yongtai Bioscience, representing 10% of Yongtai's issued share capital, for approximately HK$799.7 million. The report states that China Resources Pharmaceutical would become Yongtai's major shareholder after completion.